DD
DuPont de Nemours, Inc.
NYSE · Basic Materials · Chemicals - Specialty · US
$130.61
−0.40%Year over year
Reported trailing growth
- Revenue
- -32.7%
- EBITDA
- -32.4%
- EBIT
- -39.1%
- EPS
- +115.3%
- Free cash flow
- -14.7%
- Operating cash flow
- -34.9%
Forward estimates
Based on analyst estimates
- Revenue
- -11.5%
- EBITDA
- +50.7%
- EPS
- +1558.7%
Three-year CAGR
- Revenue
- -19.3%
- EBITDA
- -27.7%
- EBIT
- -24.8%
- Net income
- —
- EPS
- —
- Free cash flow
- -17.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026